|
WO2000022112A1
(en)
|
1998-10-13 |
2000-04-20 |
The University Of Georgia Research Foundation, Inc. |
Stabilized bioactive peptides and methods of identification, synthesis and use
|
|
US20030190740A1
(en)
|
1998-10-13 |
2003-10-09 |
The University Of Georgia Research Foundation, Inc |
Stabilized bioactive peptides and methods of identification, synthesis, and use
|
|
US20050287153A1
(en)
*
|
2002-06-28 |
2005-12-29 |
Genentech, Inc. |
Serum albumin binding peptides for tumor targeting
|
|
AU784285B2
(en)
|
1999-12-24 |
2006-03-02 |
Genentech Inc. |
Methods and compositions for prolonging elimination half-times of bioactive compounds
|
|
US20040001827A1
(en)
*
|
2002-06-28 |
2004-01-01 |
Dennis Mark S. |
Serum albumin binding peptides for tumor targeting
|
|
DE10012120A1
(de)
*
|
2000-03-13 |
2001-09-27 |
Ktb Tumorforschungs Gmbh |
Therapeutische und diagnostische Ligandensysteme mit Transportmolekülbindenden Eigenschaften und diese enthaltende Arzneimittel
|
|
DE50112802D1
(de)
|
2000-11-08 |
2007-09-13 |
Fresenius Medical Care Affina |
Peptide, deren herstellung und verwendung zur bindung von immunglobulinen
|
|
CA2440582A1
(en)
|
2001-03-09 |
2002-10-03 |
Dyax Corp. |
Serum albumin binding moieties
|
|
US20030157561A1
(en)
*
|
2001-11-19 |
2003-08-21 |
Kolkman Joost A. |
Combinatorial libraries of monomer domains
|
|
US20050271663A1
(en)
*
|
2001-06-28 |
2005-12-08 |
Domantis Limited |
Compositions and methods for treating inflammatory disorders
|
|
US20110045005A1
(en)
|
2001-10-19 |
2011-02-24 |
Craig Crowley |
Compositions and methods for the treatment of tumor of hematopoietic origin
|
|
JP2005289809A
(ja)
*
|
2001-10-24 |
2005-10-20 |
Vlaams Interuniversitair Inst Voor Biotechnologie Vzw (Vib Vzw) |
突然変異重鎖抗体
|
|
US6916904B2
(en)
*
|
2002-04-24 |
2005-07-12 |
Zolaris Biosciences, Llc |
Inhibition of immune complex formation
|
|
US20090068178A1
(en)
*
|
2002-05-08 |
2009-03-12 |
Genentech, Inc. |
Compositions and Methods for the Treatment of Tumor of Hematopoietic Origin
|
|
CA2489596A1
(en)
*
|
2002-06-14 |
2003-12-24 |
Dyax Corporation |
Protein analysis
|
|
US9321832B2
(en)
|
2002-06-28 |
2016-04-26 |
Domantis Limited |
Ligand
|
|
CA2492092A1
(en)
*
|
2002-06-28 |
2004-01-08 |
Greg Winter |
Immunoglobin single variant antigen-binding domains and dual-specific constructs
|
|
CA2505325C
(en)
|
2002-11-08 |
2014-02-25 |
Ablynx N.V. |
Stabilized single domain antibodies
|
|
US9320792B2
(en)
|
2002-11-08 |
2016-04-26 |
Ablynx N.V. |
Pulmonary administration of immunoglobulin single variable domains and constructs thereof
|
|
US20060034845A1
(en)
|
2002-11-08 |
2006-02-16 |
Karen Silence |
Single domain antibodies directed against tumor necrosis factor alpha and uses therefor
|
|
US7329725B1
(en)
*
|
2003-10-29 |
2008-02-12 |
Nastech Pharmaceutical Company Inc. |
Phage displayed Trp cage ligands
|
|
WO2005063816A2
(en)
|
2003-12-19 |
2005-07-14 |
Genentech, Inc. |
Monovalent antibody fragments useful as therapeutics
|
|
US8754031B2
(en)
|
2004-03-08 |
2014-06-17 |
Oncolix, Inc. |
Use of prolactin receptor antagonists in combination with an agent that inactivates the HER2/neu signaling pathway
|
|
EP1730170B1
(en)
|
2004-03-10 |
2020-02-19 |
Trinity Therapeutics, Inc. |
Method for inhibiting immune complex formation in a subject
|
|
AU2011253771B2
(en)
*
|
2004-03-10 |
2013-10-31 |
Trinity Therapeutics, Inc. |
Method for inhibiting immune complex formation in a subject
|
|
JP5634008B2
(ja)
*
|
2004-04-06 |
2014-12-03 |
アフィボディ・アーベー |
新規の使用および方法
|
|
JP2008500830A
(ja)
*
|
2004-06-01 |
2008-01-17 |
ドマンティス リミテッド |
増加した血清半減期を有する二重特異性融合抗体
|
|
CA2567520A1
(en)
|
2004-06-01 |
2005-12-15 |
Genentech, Inc. |
Maytansinoid-antibody conjugates
|
|
BRPI0513666A
(pt)
|
2004-08-05 |
2008-05-13 |
Genentech Inc |
anticorpos, anticorpos anti c-met humanizados, método de inibição de proliferação celular de c-met ativado, método de modulação de uma doença associada com descontrole de sinalização de hgf/c-met, método para o tratamento de um sujeito com cáncer, método para o tratamento de um distúrbio proliferativo, ácido nucléico, célula hospedeira e composição
|
|
CN104447992A
(zh)
|
2004-09-23 |
2015-03-25 |
健泰科生物技术公司 |
半胱氨酸改造的抗体和偶联物
|
|
US20100111856A1
(en)
|
2004-09-23 |
2010-05-06 |
Herman Gill |
Zirconium-radiolabeled, cysteine engineered antibody conjugates
|
|
GB0426146D0
(en)
|
2004-11-29 |
2004-12-29 |
Bioxell Spa |
Therapeutic peptides and method
|
|
EP1817059A2
(en)
|
2004-12-01 |
2007-08-15 |
Genentech, Inc. |
Conjugates of 1,8-bis-naphthalimides with an antibody
|
|
CA2588892A1
(en)
*
|
2004-12-02 |
2006-06-08 |
Dormantis Limited |
Anti-il-1r1 single domain antibodies and therapeutic uses
|
|
BRPI0518762A2
(pt)
*
|
2004-12-02 |
2008-12-09 |
Domantis Ltd |
fusço de droga, conjugado de droga, Ácido nucleico recombinante ou isolado, construÇço de Ácido nucleico, cÉlula hospedeira, mÉtodo para produzir a fusço de droga, composiÇço farmacÊutica, mÉtodo para tratamento de um indivÍduo tendo uma doenÇa inflamatària, uso de um conjugado de droga ou fusço de droga, e, composiÇço de droga
|
|
KR20070094909A
(ko)
*
|
2004-12-02 |
2007-09-27 |
도만티스 리미티드 |
혈청 알부민 및 ｇｌｐ-1 또는 ｐｙｙ를 표적으로 삼는이중특이성 도메인을 갖는 항체
|
|
BR122013001996B1
(pt)
|
2005-05-18 |
2022-02-01 |
Ablynx N.V. |
Nanocorpos melhorados contra fator alfa de necrose tumoral
|
|
DE102005023617A1
(de)
|
2005-05-21 |
2006-11-23 |
Aspre Ag |
Verfahren zum Mischen von Farben in einem Display
|
|
US20080187490A1
(en)
*
|
2005-09-06 |
2008-08-07 |
Bodie Neil M |
Methods for Treating Amyotrophic Lateral Sclerosis
|
|
EP1940880A2
(en)
*
|
2005-10-14 |
2008-07-09 |
Novo Nordisk A/S |
Treating diabetes using inhibitors of il-1
|
|
JP5808070B2
(ja)
|
2005-12-02 |
2015-11-10 |
ジェネンテック， インコーポレイテッド |
結合ポリペプチド及びその使用
|
|
US7704953B2
(en)
*
|
2006-02-17 |
2010-04-27 |
Mdrna, Inc. |
Phage displayed cell binding peptides
|
|
WO2007104789A2
(en)
|
2006-03-15 |
2007-09-20 |
Novo Nordisk A/S |
Amylin derivatives
|
|
SG172656A1
(en)
|
2006-05-30 |
2011-07-28 |
Genentech Inc |
Antibodies and immunoconjugates and uses therefor
|
|
EP2086998B1
(en)
*
|
2006-10-11 |
2011-12-07 |
Ablynx N.V. |
Amino acid sequences that bind to serum proteins in a manner that is essentially independent of the ph, compounds comprising the same, and use thereof
|
|
WO2008052187A2
(en)
|
2006-10-27 |
2008-05-02 |
Genentech. Inc. |
Antibodies and immunoconjugates and uses therefor
|
|
CA2672386A1
(en)
*
|
2006-12-13 |
2008-06-19 |
Ablynx N.V. |
Polypeptides specific for complexes involved in receptor-mediated signaling, such as the il-6/il-6 receptor complex
|
|
KR20140031996A
(ko)
|
2006-12-19 |
2014-03-13 |
제넨테크, 인크. |
조기 종양의 치료 및 아주반트 및 네오아주반트 요법을 위한 ｖｅｇｆ－특이적 길항제
|
|
US9512236B2
(en)
|
2006-12-19 |
2016-12-06 |
Ablynx N.V. |
Amino acid sequences directed against GPCRS and polypeptides comprising the same for the treatment of GPCR-related diseases and disorders
|
|
AU2007336243B2
(en)
|
2006-12-19 |
2012-07-26 |
Ablynx N.V. |
Amino acid sequences directed against a metalloproteinase from the ADAM family and polypeptides comprising the same for the treatment of ADAM-related diseases and disorders
|
|
EP2115004A2
(en)
|
2006-12-19 |
2009-11-11 |
Ablynx N.V. |
Amino acid sequences directed against gpcrs and polypeptides comprising the same for the treatment of gpcr-related diseases and disorders
|
|
MX2009008430A
(es)
|
2007-02-09 |
2009-10-28 |
Genentech Inc |
Anticuerpos anti-robo4 y sus usos.
|
|
CN101802013B
(zh)
|
2007-07-16 |
2014-07-02 |
健泰科生物技术公司 |
人源化抗cd79b抗体和免疫偶联物及使用方法
|
|
PL2176296T3
(pl)
|
2007-07-16 |
2012-07-31 |
Genentech Inc |
Przeciwciała anty-CD79B i immunokoniugaty i sposoby stosowania
|
|
ES2346178T3
(es)
|
2007-07-31 |
2015-11-02 |
Affibody Ab |
Nuevas composiciones, procedimientos y usos de unión de la albúmina
|
|
EP2036923A1
(en)
*
|
2007-09-11 |
2009-03-18 |
Novo Nordisk A/S |
Improved derivates of amylin
|
|
WO2009040562A1
(en)
|
2007-09-26 |
2009-04-02 |
Ucb Pharma S.A. |
Dual specificity antibody fusions
|
|
KR100920729B1
(ko)
*
|
2007-10-01 |
2009-10-07 |
한국생명공학연구원 |
펩타이드 혼성체를 사용한 배향성이 조절된 항체단분자막의 제조방법
|
|
WO2009068631A1
(en)
|
2007-11-27 |
2009-06-04 |
Ablynx N.V. |
Method for obtaining polypeptide constructs comprising two or more single domain antibodies
|
|
SI2247620T1
(sl)
|
2008-01-31 |
2016-09-30 |
Genentech, Inc. |
Protitelesa proti CD79b in imunokonjugati in postopki za uporabo
|
|
US8557965B2
(en)
|
2008-04-07 |
2013-10-15 |
Ablynx N.V. |
Single variable domains against notch pathway members
|
|
US9212226B2
(en)
|
2008-05-16 |
2015-12-15 |
Ablynx N.V. |
Amino acid sequences directed against CXCR4 and other GPCRs and compounds comprising the same
|
|
JP5809557B2
(ja)
|
2008-06-05 |
2015-11-11 |
アブリンクス エン．ヴェー． |
ウイルスのエンベロープタンパク質に指向性を有するアミノ酸配列、及びウイルス疾患の治療のためのこれを含むポリペプチド
|
|
JP5988580B2
(ja)
|
2008-06-30 |
2016-09-07 |
エスバテック − ア ノバルティス カンパニー エルエルシー |
機能性ポリペプチド
|
|
CN104800147A
(zh)
|
2008-07-10 |
2015-07-29 |
德勒尼克斯治疗股份公司 |
用于大分子的增强的递送的方法和组合物
|
|
BRPI0915968B1
(pt)
*
|
2008-07-18 |
2021-11-23 |
Trinity Therapeutics, inc |
Uso de polipeptídeo purificado para tratar infecção pelo vírus da dengue
|
|
WO2010035012A1
(en)
|
2008-09-26 |
2010-04-01 |
Ucb Pharma S.A. |
Biological products
|
|
ES2662501T3
(es)
|
2008-10-21 |
2018-04-06 |
Novo Nordisk A/S |
Derivados de amilina
|
|
RU2553214C2
(ru)
|
2008-10-29 |
2015-06-10 |
Аблинкс Н.В. |
Способы очистки однодоменных антигенсвязывающих молекул
|
|
BR122018013284B1
(pt)
|
2008-10-29 |
2022-03-03 |
Ablynx N.V |
Formulações de moléculas de ligação ao antígeno de domínio único, seu método de formulação e seu uso, kit ou artigo de fabricação, bem como método para preparar uma formulação reconstituída contendo uma molécula de sdab
|
|
WO2010054699A1
(en)
*
|
2008-11-17 |
2010-05-20 |
Affibody Ab |
Conjugates of albumin binding domain
|
|
HUE032693T2
(en)
|
2008-11-22 |
2017-10-30 |
Hoffmann La Roche |
Use of anti-vegf antibody in combination with chemotherapy for treating breast cancer
|
|
WO2010070145A2
(en)
|
2008-12-19 |
2010-06-24 |
Ablynx N.V. |
Method for generation of immunoglobulin sequences
|
|
US8648046B2
(en)
*
|
2009-02-26 |
2014-02-11 |
Oncolix, Inc. |
Compositions and methods for visualizing and eliminating cancer stem cells
|
|
JP5963443B2
(ja)
*
|
2009-02-26 |
2016-08-03 |
オンコリックス， インコーポレイテッド |
がん幹細胞を可視化・排除するための組成物および方法
|
|
HUE061117T2
(hu)
|
2009-03-25 |
2023-05-28 |
Genentech Inc |
Anti-FGFR3 antitestek és eljárások alkalmazásukra
|
|
SG174992A1
(en)
|
2009-04-01 |
2011-11-28 |
Genentech Inc |
Anti-fcrh5 antibodies and immunoconjugates and methods of use
|
|
AU2010233658B2
(en)
|
2009-04-10 |
2013-11-28 |
Ablynx Nv |
Improved amino acid sequences directed against IL-6R and polypeptides comprising the same for the treatment of IL-6R related diseases and disorders
|
|
AU2010255638B2
(en)
|
2009-06-05 |
2014-10-16 |
Ablynx Nv |
Monovalent, bivalent and trivalent anti human respiratory syncytial virus (hRSV) nanobody constructs for the prevention and/or treatment of respiratory tract infections
|
|
AU2010284446A1
(en)
|
2009-08-15 |
2012-03-08 |
Genentech, Inc. |
Anti-angiogenesis therapy for the treatment of previously treated breast cancer
|
|
EP2475391B1
(en)
|
2009-09-09 |
2018-09-12 |
Centrose, LLC |
Extracellular targeted drug conjugates
|
|
GB201005063D0
(en)
|
2010-03-25 |
2010-05-12 |
Ucb Pharma Sa |
Biological products
|
|
WO2011050188A1
(en)
|
2009-10-22 |
2011-04-28 |
Genentech, Inc. |
Anti-hepsin antibodies and methods using same
|
|
ES2636971T3
(es)
|
2009-11-05 |
2017-10-10 |
F. Hoffmann-La Roche Ag |
Procedimientos y composición para la secreción de polipéptidos heterógenos
|
|
RU2579977C2
(ru)
|
2009-11-13 |
2016-04-10 |
Грифольс Терапьютикс Инк. |
СОДЕРЖАЩИЕ ФАКТОР ФОН ВИЛЛЕБРАНДА (vWF) ПРЕПАРАТЫ И СПОСОБЫ, НАБОРЫ И ПРИМЕНЕНИЯ, СВЯЗАННЫЕ С НИМИ
|
|
EP2507262A1
(en)
|
2009-11-30 |
2012-10-10 |
Ablynx N.V. |
Improved amino acid sequences directed against human respiratory syncytial virus (hrsv) and polypeptides comprising the same for the prevention and/or treatment of respiratory tract infections
|
|
CN107337734A
(zh)
|
2009-12-04 |
2017-11-10 |
弗·哈夫曼-拉罗切有限公司 |
多特异性抗体、抗体类似物、组合物和方法
|
|
US20120269830A1
(en)
|
2009-12-07 |
2012-10-25 |
Lawrence Horowitz |
Conjugates with improved pharmacokinetic properties
|
|
EP2513145B1
(en)
|
2009-12-14 |
2018-01-24 |
Ablynx N.V. |
Single variable domain antibodies against ox40l, constructs and therapeutic use
|
|
WO2011083141A2
(en)
|
2010-01-08 |
2011-07-14 |
Ablynx Nv |
Method for generation of immunoglobulin sequences by using lipoprotein particles
|
|
US9120855B2
(en)
|
2010-02-10 |
2015-09-01 |
Novartis Ag |
Biologic compounds directed against death receptor 5
|
|
WO2011106300A2
(en)
|
2010-02-23 |
2011-09-01 |
Genentech, Inc. |
Anti-angiogenesis therapy for the treatment of ovarian cancer
|
|
WO2011117423A1
(en)
|
2010-03-26 |
2011-09-29 |
Ablynx N.V. |
Immunoglobulin single variable domains directed against cxcr7
|
|
CN102933236B
(zh)
|
2010-04-15 |
2014-10-08 |
斯皮罗根有限公司 |
吡咯并苯二氮卓类及其结合物
|
|
PH12012502272A1
(en)
|
2010-05-20 |
2017-07-26 |
Ablynx Nv |
Biological materials related to her3
|
|
WO2011153243A2
(en)
|
2010-06-02 |
2011-12-08 |
Genentech, Inc. |
Anti-angiogenesis therapy for treating gastric cancer
|
|
NZ602840A
(en)
|
2010-06-03 |
2014-11-28 |
Genentech Inc |
Immuno-pet imaging of antibodies and immunoconjugates and uses therefor
|
|
MX336540B
(es)
|
2010-06-08 |
2016-01-22 |
Genentech Inc |
Conjugados y anticuerpos manipulados geneticamente con cisteina.
|
|
KR101884654B1
(ko)
|
2010-07-09 |
2018-08-02 |
애피바디 에이비 |
폴리펩타이드
|
|
JP6121330B2
(ja)
|
2010-09-28 |
2017-04-26 |
アミリン・ファーマシューティカルズ, リミテッド・ライアビリティ・カンパニーAmylin Pharmaceuticals, Llc |
作用持続時間が増した改変ポリペプチド
|
|
EP2621953B1
(en)
|
2010-09-30 |
2017-04-05 |
Ablynx N.V. |
Biological materials related to c-met
|
|
SG189981A1
(en)
|
2010-11-08 |
2013-06-28 |
Novartis Ag |
Cxcr2 binding polypeptides
|
|
ES2544608T3
(es)
|
2010-11-17 |
2015-09-02 |
Genentech, Inc. |
Conjugados de anticuerpo y de alaninil-maitansinol
|
|
US9284361B2
(en)
|
2010-11-26 |
2016-03-15 |
Molecular Partners Ag |
Designed repeat proteins binding to serum albumin
|
|
CA2827170A1
(en)
|
2011-02-11 |
2012-08-16 |
David M. Hilbert |
Monovalent and multivalent multispecific complexes and uses thereof
|
|
CN103917560B
(zh)
|
2011-03-28 |
2017-05-24 |
埃博灵克斯股份有限公司 |
双特异性抗‑cxcr7免疫球蛋白单可变结构域
|
|
UA117218C2
(uk)
|
2011-05-05 |
2018-07-10 |
Мерк Патент Гмбх |
Поліпептид, спрямований проти il-17a, il-17f та/або il17-a/f
|
|
WO2012155019A1
(en)
|
2011-05-12 |
2012-11-15 |
Genentech, Inc. |
Multiple reaction monitoring lc-ms/ms method to detect therapeutic antibodies in animal samples using framework signature pepides
|
|
CA2835340A1
(en)
|
2011-05-27 |
2012-12-06 |
Ablynx Nv |
Inhibition of bone resorption with rankl binding peptides
|
|
WO2012175740A1
(en)
|
2011-06-23 |
2012-12-27 |
Ablynx Nv |
Immunoglobulin single variable domains directed against ige
|
|
AU2012275233A1
(en)
|
2011-06-30 |
2013-11-28 |
Genentech, Inc. |
Anti-c-met antibody formulations
|
|
JP2014522641A
(ja)
|
2011-07-01 |
2014-09-08 |
バイエル・インテレクチュアル・プロパティ・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング |
リラキシン融合ポリペプチドおよびその使用
|
|
BR112014000474A2
(pt)
|
2011-07-08 |
2017-02-21 |
Bayer Ip Gmbh |
proteínas de fusão libertadoras de relaxina e suas utilizações
|
|
US20130022551A1
(en)
|
2011-07-22 |
2013-01-24 |
Trustees Of Boston University |
DEspR ANTAGONISTS AND AGONISTS AS THERAPEUTICS
|
|
CN103890174B
(zh)
|
2011-08-24 |
2015-12-23 |
大塚化学株式会社 |
IgG结合性肽及利用其检测和纯化IgG的方法
|
|
EP2747782B1
(en)
|
2011-09-23 |
2018-01-17 |
Ablynx NV |
Prolonged inhibition of interleukin-6 mediated signaling
|
|
SG10201504605RA
(en)
|
2011-09-23 |
2015-07-30 |
Technophage Investigação E Desenvolvimento Em Biotecnologia Sa |
Anti-Tumor Necrosis Factor-Alpha Agents And Uses Thereof
|
|
WO2013043071A1
(en)
|
2011-09-23 |
2013-03-28 |
Technophage, Investigação E Desenvolvimento Em Biotecnologia, Sa |
Modified albumin-binding domains and uses thereof to improve pharmacokinetics
|
|
EP2747783B1
(en)
|
2011-09-30 |
2017-06-14 |
Ablynx N.V. |
Biological materials related to c-met
|
|
DK2750713T3
(en)
|
2011-10-14 |
2015-12-21 |
Medimmune Ltd |
PYRROLOBENZODIAZEPINS AND CONJUGATES THEREOF
|
|
HUE037142T2
(hu)
|
2011-11-11 |
2018-08-28 |
Ucb Biopharma Sprl |
Albumin-kötõ ellenanyagok és kötõfragmenseik
|
|
US20150037334A1
(en)
*
|
2012-03-01 |
2015-02-05 |
Amgen Research (Munich) Gmbh |
Long life polypeptide binding molecules
|
|
WO2013130093A1
(en)
|
2012-03-02 |
2013-09-06 |
Genentech, Inc. |
Biomarkers for treatment with anti-tubulin chemotherapeutic compounds
|
|
JP2020033372A
(ja)
*
|
2012-03-28 |
2020-03-05 |
アフィボディ・アーベー |
経口投与
|
|
EP2830665A1
(en)
|
2012-03-28 |
2015-02-04 |
Affibody AB |
Oral administration
|
|
US9328174B2
(en)
|
2012-05-09 |
2016-05-03 |
Novartis Ag |
Chemokine receptor binding polypeptides
|
|
US8822423B2
(en)
*
|
2012-05-17 |
2014-09-02 |
Janssen Biotech, Inc. |
Affinity peptides toward infliximab
|
|
US9289507B2
(en)
|
2012-05-17 |
2016-03-22 |
Extend Biosciences, Inc. |
Carriers for improved drug delivery
|
|
WO2013177398A2
(en)
|
2012-05-25 |
2013-11-28 |
Janssen Biotech, Inc. |
Non-natural consensus albumin binding domains
|
|
WO2013177481A1
(en)
|
2012-05-25 |
2013-11-28 |
Immunogen, Inc. |
Benzodiazepines and conjugates thereof
|
|
WO2013192546A1
(en)
*
|
2012-06-22 |
2013-12-27 |
Cytomx Therapeutics, Inc. |
Activatable antibodies having non-binding steric moieties and mehtods of using the same
|
|
WO2014003176A1
(ja)
*
|
2012-06-29 |
2014-01-03 |
旭化成メディカル株式会社 |
プロテインａのｂドメイン変異体を含むポリペプチドが結合された担体からなる吸着材
|
|
KR102123457B1
(ko)
|
2012-09-25 |
2020-06-16 |
애피바디 에이비 |
알부민 결합 폴리펩타이드
|
|
ES2847050T3
(es)
|
2012-10-12 |
2021-07-30 |
Medimmune Ltd |
Pirrolobenzodiazepinas y conjugados de las mismas
|
|
AU2013328625B2
(en)
|
2012-10-12 |
2016-12-15 |
Adc Therapeutics Sa |
Pyrrolobenzodiazepine-antibody conjugates
|
|
SI2766048T1
(sl)
|
2012-10-12 |
2015-03-31 |
Spirogen Sarl |
Pirolobenzodiazepini in njihovi konjugati
|
|
DK2906298T3
(en)
|
2012-10-12 |
2018-12-17 |
Adc Therapeutics Sa |
Pyrrolobenzodiazepine-antibody conjugates
|
|
BR112015008173A2
(pt)
|
2012-10-12 |
2017-11-28 |
Adc Therapeutics Sarl |
conjugados de pirrolobenzodiazepina-anticorpo anti-psma
|
|
EP2906251B1
(en)
|
2012-10-12 |
2017-09-27 |
ADC Therapeutics SA |
Pyrrolobenzodiazepine-anti-cd22 antibody conjugates
|
|
WO2014057114A1
(en)
|
2012-10-12 |
2014-04-17 |
Adc Therapeutics Sàrl |
Pyrrolobenzodiazepine-anti-psma antibody conjugates
|
|
ES2660029T3
(es)
|
2012-10-12 |
2018-03-20 |
Medimmune Limited |
Conjugados de anticuerpo-pirrolobenzodiazepinas
|
|
PL2912051T3
(pl)
|
2012-10-25 |
2018-08-31 |
Affibody Ab |
Sposób rozdzielania białek zawierających domenę wiążącą albuminę
|
|
DK2912054T3
(en)
|
2012-10-25 |
2017-09-11 |
Affibody Ab |
Albumin-binding polypeptide
|
|
US9562049B2
(en)
|
2012-12-21 |
2017-02-07 |
Medimmune Limited |
Pyrrolobenzodiazepines and conjugates thereof
|
|
WO2014096365A1
(en)
|
2012-12-21 |
2014-06-26 |
Spirogen Sàrl |
Unsymmetrical pyrrolobenzodiazepines-dimers for use in the treatment of proliferative and autoimmune diseases
|
|
EP2752426A1
(en)
|
2013-01-03 |
2014-07-09 |
Covagen AG |
Human serum albumin binding compounds and fusion proteins thereof
|
|
WO2014115229A1
(ja)
|
2013-01-28 |
2014-07-31 |
独立行政法人産業技術総合研究所 |
抗体結合性ペプチド
|
|
EP2968594B1
(en)
|
2013-03-13 |
2019-04-24 |
Medimmune Limited |
Pyrrolobenzodiazepines and conjugates thereof
|
|
EA027910B1
(ru)
|
2013-03-13 |
2017-09-29 |
Медимьюн Лимитед |
Пирролобензодиазепины и их конъюгаты
|
|
CN105209077B
(zh)
|
2013-03-13 |
2019-06-11 |
麦迪穆有限责任公司 |
吡咯并苯并二氮杂卓以及其结合物
|
|
US20160152686A1
(en)
|
2013-03-13 |
2016-06-02 |
Bristol-Myers Squibb Company |
Fibronectin based scaffold domains linked to serum albumin or moiety binding thereto
|
|
AR095596A1
(es)
|
2013-03-15 |
2015-10-28 |
Amgen Res Munich Gmbh |
Moléculas de unión de cadena única comprendiendo n-terminal abp
|
|
TWI636792B
(zh)
|
2013-08-12 |
2018-10-01 |
建南德克公司 |
１－（氯甲基）－２，３－二氫－１ｈ－苯并［ｅ］吲哚二聚體抗體－藥物結合物化合物及使用與治療方法
|
|
WO2015052535A1
(en)
|
2013-10-11 |
2015-04-16 |
Spirogen Sàrl |
Pyrrolobenzodiazepine-antibody conjugates
|
|
US10010624B2
(en)
|
2013-10-11 |
2018-07-03 |
Medimmune Limited |
Pyrrolobenzodiazepine-antibody conjugates
|
|
GB201317982D0
(en)
|
2013-10-11 |
2013-11-27 |
Spirogen Sarl |
Pyrrolobenzodiazepines and conjugates thereof
|
|
WO2015052534A1
(en)
|
2013-10-11 |
2015-04-16 |
Spirogen Sàrl |
Pyrrolobenzodiazepine-antibody conjugates
|
|
JP6895254B2
(ja)
|
2013-12-16 |
2021-06-30 |
ジェネンテック， インコーポレイテッド |
ペプチド模倣化合物及びその抗体−薬物コンジュゲート
|
|
KR102354207B1
(ko)
|
2013-12-16 |
2022-01-20 |
제넨테크, 인크. |
펩티드모방체 화합물 및 그의 항체-약물 접합체
|
|
MX2016007578A
(es)
|
2013-12-16 |
2016-10-03 |
Genentech Inc |
Compuestos de conjugado anticuerpo-farmaco dimerico de 1-(clorometil)-2,3-dihidro-1h-benzo [e] indol, y metodos de uso y tratamiento.
|
|
US10167322B2
(en)
|
2013-12-20 |
2019-01-01 |
Affibody Ab |
Engineered albumin binding polypeptide
|
|
WO2015132248A2
(en)
*
|
2014-03-03 |
2015-09-11 |
Vrije Universiteit Brussel (Vub) |
Sequamers - a novel non-natural type of peptide libraries randomly constrained by their primary sequences
|
|
ES2897765T3
(es)
|
2014-03-14 |
2022-03-02 |
Hoffmann La Roche |
Procedimientos y composiciones para la secreción de polipéptidos heterólogos
|
|
CN107002119A
(zh)
|
2014-03-24 |
2017-08-01 |
豪夫迈·罗氏有限公司 |
使用c‑met拮抗剂的癌症治疗及前者与hgf表达的关联
|
|
EP2940128A1
(en)
|
2014-04-30 |
2015-11-04 |
Institut d'Investigació Biomèdica de Bellvitge (IDIBELL) |
Adenovirus comprising an albumin-binding moiety
|
|
JP2017518965A
(ja)
*
|
2014-05-02 |
2017-07-13 |
モメンタ ファーマシューティカルズ インコーポレイテッ |
エンジニアリングされたＦｃ構築物に関連する組成物および方法
|
|
NL2013661B1
(en)
|
2014-10-21 |
2016-10-05 |
Ablynx Nv |
KV1.3 Binding immunoglobulins.
|
|
US10188746B2
(en)
|
2014-09-10 |
2019-01-29 |
Medimmune Limited |
Pyrrolobenzodiazepines and conjugates thereof
|
|
GB201416112D0
(en)
|
2014-09-12 |
2014-10-29 |
Medimmune Ltd |
Pyrrolobenzodiazepines and conjugates thereof
|
|
MX2017003123A
(es)
|
2014-09-12 |
2017-05-12 |
Genentech Inc |
Anticuerpos y conjugados modificados geneticamente con cisteina.
|
|
EP3191134B1
(en)
|
2014-09-12 |
2019-11-20 |
Genentech, Inc. |
Anthracycline disulfide intermediates, antibody-drug conjugates and methods
|
|
BR112017005393A2
(pt)
|
2014-09-17 |
2017-12-05 |
Genentech Inc |
composto de fórmula i, método de preparação de um conjugado de fórmula a, conjugado de fórmula a1, composição compreendendo uma mistura dos compostos de conjugado de anticorpo-fármaco, composição farmacêutica, e uso de um conjugado ou de uma composição
|
|
CA2979671C
(en)
|
2014-09-23 |
2020-03-10 |
Genentech, Inc. |
Methods of using anti-cd79b immunoconjugates
|
|
WO2016065042A1
(en)
|
2014-10-22 |
2016-04-28 |
Extend Biosciences, Inc. |
Therapeutic vitamin d conjugates
|
|
WO2016065052A1
(en)
|
2014-10-22 |
2016-04-28 |
Extend Biosciences, Inc. |
Insulin vitamin d conjugates
|
|
US9789197B2
(en)
|
2014-10-22 |
2017-10-17 |
Extend Biosciences, Inc. |
RNAi vitamin D conjugates
|
|
CA2961439A1
(en)
|
2014-11-05 |
2016-05-12 |
Genentech, Inc. |
Anti-fgfr2/3 antibodies and methods using same
|
|
BR112017011111A2
(pt)
|
2014-11-25 |
2017-12-26 |
Adc Therapeutics Sa |
conjugados de pirrolobenzodiazepina-anticorpo
|
|
KR20170086121A
(ko)
|
2014-12-03 |
2017-07-25 |
제넨테크, 인크. |
4급 아민 화합물 및 그의 항체-약물 접합체
|
|
ES2981606T3
(es)
|
2014-12-19 |
2024-10-09 |
Inozyme Pharma Inc |
NPP1 soluble para su uso en un método para el tratamiento del pseudoxantoma elástico
|
|
US10273305B2
(en)
|
2015-04-02 |
2019-04-30 |
Ablynx N.V. |
Bispecific CXCR4-CD4 polypeptides with potent anti-HIV activity
|
|
JP6892433B2
(ja)
|
2015-04-03 |
2021-06-23 |
ユニバーシティ・オブ・マサチューセッツＵｎｉｖｅｒｓｉｔｙ Ｏｆ Ｍａｓｓａｃｈｕｓｅｔｔｓ |
十分に安定化された非対称ｓｉｒｎａ
|
|
DK3280432T3
(da)
|
2015-04-06 |
2021-04-26 |
Subdomain Llc |
Polypeptider indeholdende de novo-bindingsdomæner og anvendelser deraf
|
|
GB201506402D0
(en)
|
2015-04-15 |
2015-05-27 |
Berkel Patricius H C Van And Howard Philip W |
Site-specific antibody-drug conjugates
|
|
GB201506411D0
(en)
|
2015-04-15 |
2015-05-27 |
Bergenbio As |
Humanized anti-axl antibodies
|
|
PL3294768T3
(pl)
|
2015-05-13 |
2020-03-31 |
Ablynx N.V. |
Polipeptydy rekrutujące komórki T oparte na reaktywności TCR alfa/beta
|
|
EP3294319B1
(en)
|
2015-05-13 |
2024-04-24 |
Ablynx NV |
T cell recruiting polypeptides based on cd3 reactivity
|
|
WO2016193380A1
(en)
|
2015-06-02 |
2016-12-08 |
Novo Nordisk A/S |
Insulins with polar recombinant extensions
|
|
CA2995110A1
(en)
|
2015-08-14 |
2017-02-23 |
University Of Massachusetts |
Bioactive conjugates for oligonucleotide delivery
|
|
MA43348A
(fr)
|
2015-10-01 |
2018-08-08 |
Novo Nordisk As |
Conjugués de protéines
|
|
EP3366693B1
(en)
*
|
2015-10-23 |
2023-08-16 |
FUJIFILM Corporation |
Cyclic peptide, affinity chromatography support, labeled antibody, antibody-drug conjugate, and pharmaceutical preparation
|
|
TN2018000180A1
(en)
|
2015-11-27 |
2019-10-04 |
Ablynx Nv |
Polypeptides inhibiting cd40l
|
|
GB201601431D0
(en)
|
2016-01-26 |
2016-03-09 |
Medimmune Ltd |
Pyrrolobenzodiazepines
|
|
AU2017210726B2
(en)
|
2016-01-31 |
2023-08-03 |
University Of Massachusetts |
Branched oligonucleotides
|
|
GB201602356D0
(en)
|
2016-02-10 |
2016-03-23 |
Medimmune Ltd |
Pyrrolobenzodiazepine Conjugates
|
|
GB201602359D0
(en)
|
2016-02-10 |
2016-03-23 |
Medimmune Ltd |
Pyrrolobenzodiazepine Conjugates
|
|
WO2017151707A1
(en)
|
2016-03-01 |
2017-09-08 |
The Board Of Trustees Of The University Of Illinois |
L-asparaginase variants and fusion proteins with reduced l-glutaminase activity and enhanced stability
|
|
EP3423572B1
(en)
|
2016-03-02 |
2023-11-29 |
Momenta Pharmaceuticals, Inc. |
Methods related to engineered fc constructs
|
|
EP3433621A1
(en)
|
2016-03-25 |
2019-01-30 |
H. Hoffnabb-La Roche Ag |
Multiplexed total antibody and antibody-conjugated drug quantification assay
|
|
EP3446102B1
(en)
|
2016-04-15 |
2025-12-10 |
Bruker Cellular Analysis, Inc. |
Methods, systems, computer program and non-transitory computer-readable medium for in-pen assays
|
|
GB201607478D0
(en)
|
2016-04-29 |
2016-06-15 |
Medimmune Ltd |
Pyrrolobenzodiazepine Conjugates
|
|
WO2017205436A1
(en)
|
2016-05-23 |
2017-11-30 |
Momenta Pharmaceuticals, Inc. |
Compositions and methods related to engineered fc constructs
|
|
EP3465221B1
(en)
|
2016-05-27 |
2020-07-22 |
H. Hoffnabb-La Roche Ag |
Bioanalytical method for the characterization of site-specific antibody-drug conjugates
|
|
EP3463430B1
(en)
|
2016-06-03 |
2025-01-01 |
Janssen Biotech, Inc. |
Serum albumin-binding fibronectin type iii domains
|
|
US11364284B2
(en)
|
2016-06-16 |
2022-06-21 |
Inozyme Pharma, Inc. |
Methods of treating myointimal proliferation
|
|
WO2018007442A1
(en)
|
2016-07-06 |
2018-01-11 |
Ablynx N.V. |
Treatment of il-6r related diseases
|
|
WO2018029182A1
(en)
|
2016-08-08 |
2018-02-15 |
Ablynx N.V. |
Il-6r single variable domain antibodies for treatment of il-6r related diseases
|
|
WO2018031933A2
(en)
|
2016-08-12 |
2018-02-15 |
University Of Massachusetts |
Conjugated oligonucleotides
|
|
US11008365B2
(en)
|
2016-09-01 |
2021-05-18 |
National Institute Of Advanced Industrial Science And Technology |
Polypeptide exhibiting affinity to antibodies forming non-native three-dimensional structure
|
|
US11098113B2
(en)
|
2016-09-15 |
2021-08-24 |
Vib Vzw |
Immunoglobulin single variable domains directed against macrophage migration inhibitory factor
|
|
BR112019006301A2
(pt)
|
2016-09-30 |
2019-07-30 |
Fujifilm Corp |
peptídeo cíclico, suporte de cromatografia de afinidade, anticorpo marcado, conjugado anticorpo - fármaco, e preparação farmacêutica
|
|
GB201617466D0
(en)
|
2016-10-14 |
2016-11-30 |
Medimmune Ltd |
Pyrrolobenzodiazepine conjugates
|
|
EP3538560A4
(en)
|
2016-11-10 |
2020-06-17 |
Keros Therapeutics, Inc. |
GDNF FUSION POLYPEPTIDES AND METHOD FOR USE THEREOF
|
|
JP7222888B2
(ja)
|
2016-11-16 |
2023-02-15 |
アブリンクス エン．ヴェー． |
Ｃｄ１２３及びｔｃｒアルファ／ベータに結合することが可能なｔ細胞動員ポリペプチド
|
|
US11220531B2
(en)
|
2017-01-06 |
2022-01-11 |
Janssen Biotech, Inc. |
Engineered Fc constructs
|
|
US11160872B2
(en)
|
2017-02-08 |
2021-11-02 |
Adc Therapeutics Sa |
Pyrrolobenzodiazepine-antibody conjugates
|
|
GB201702031D0
(en)
|
2017-02-08 |
2017-03-22 |
Medlmmune Ltd |
Pyrrolobenzodiazepine-antibody conjugates
|
|
JP2020513019A
(ja)
|
2017-04-05 |
2020-04-30 |
ノヴォ ノルディスク アー／エス |
オリゴマー伸長インスリン−Ｆｃコンジュゲート
|
|
PL3612537T3
(pl)
|
2017-04-18 |
2022-11-07 |
Medimmune Limited |
Koniugaty pirolobenzodiazepin
|
|
MX2019012464A
(es)
|
2017-04-20 |
2019-12-11 |
Adc Therapeutics Sa |
Terapia combinada con un conjugado de anticuerpo y farmaco anti-axl.
|
|
KR20240111015A
(ko)
|
2017-04-28 |
2024-07-16 |
아지노모토 가부시키가이샤 |
가용성 단백질에 대한 친화성 물질, 절단성 부분 및 반응성기를 갖는 화합물 또는 이의 염
|
|
KR20250011229A
(ko)
|
2017-06-02 |
2025-01-21 |
메르크 파텐트 게엠베하 |
Adamts 결합성 면역글로불린
|
|
AU2018278275B2
(en)
|
2017-06-02 |
2025-06-05 |
Ablynx N.V. |
MMP13 binding immunoglobulins
|
|
US11603401B2
(en)
|
2017-06-02 |
2023-03-14 |
Ablynx N.V. |
Aggrecan binding immunoglobulins
|
|
CN110997717A
(zh)
|
2017-06-02 |
2020-04-10 |
默克专利股份有限公司 |
结合adamts5、mmp13和聚蛋白聚糖的多肽
|
|
UA127900C2
(uk)
|
2017-06-14 |
2024-02-07 |
Ейдісі Терапьютікс Са |
Схема дозування для введення adc до cd19
|
|
JP7406793B2
(ja)
|
2017-06-23 |
2023-12-28 |
ユニバーシティー オブ マサチューセッツ |
２テイル自己デリバリー型ｓｉＲＮＡおよび関連方法
|
|
EP3625265A1
(en)
|
2017-07-11 |
2020-03-25 |
Alexion Pharmaceuticals, Inc. |
Polypeptides that bind complement component c5 or serum albumin and fusion proteins thereof
|
|
WO2019032827A1
(en)
*
|
2017-08-09 |
2019-02-14 |
Massachusetts Institute Of Technology |
PEPTIDE ALBUMIN BINDING CONJUGATES AND METHODS THEREOF
|
|
CN111050784B
(zh)
|
2017-08-11 |
2024-03-19 |
伊利诺伊大学理事会 |
截短的豚鼠l-天冬酰胺酶变体及其使用方法
|
|
SI3668874T1
(sl)
|
2017-08-18 |
2022-04-29 |
Medimmune Limited |
Pirolobenzodiazepinski konjugati
|
|
EP3687565A1
(en)
|
2017-09-27 |
2020-08-05 |
Alexion Pharmaceuticals, Inc. |
Methods of improving cardiovascular function and treating cardiovascular disease using a recombinant ectonucleotide pyrophosphatase phosphodiesterase (npp1)
|
|
SG11202002982YA
(en)
|
2017-10-10 |
2020-04-29 |
Numab Therapeutics AG |
Multispecific antibody
|
|
WO2019075476A2
(en)
|
2017-10-15 |
2019-04-18 |
Berkeley Lights, Inc. |
METHODS, SYSTEMS AND KITS FOR ENCLOSED TESTS
|
|
US11377482B2
(en)
|
2017-11-14 |
2022-07-05 |
Arcellx, Inc. |
D-domain containing polypeptides and uses thereof
|
|
IL274677B2
(en)
|
2017-11-14 |
2025-01-01 |
Arcellx Inc |
Therapies with multifunctional immune system cells
|
|
WO2019107962A2
(ko)
*
|
2017-11-29 |
2019-06-06 |
아주대학교 산학협력단 |
항체와 생리활성물질의 접합방법
|
|
KR102037336B1
(ko)
|
2017-11-29 |
2019-10-29 |
아주대학교산학협력단 |
항체와 생리활성물질의 접합방법
|
|
GB201803342D0
(en)
|
2018-03-01 |
2018-04-18 |
Medimmune Ltd |
Methods
|
|
GB201806022D0
(en)
|
2018-04-12 |
2018-05-30 |
Medimmune Ltd |
Pyrrolobenzodiazepines and conjugates thereof
|
|
CN112261954B
(zh)
|
2018-06-14 |
2025-06-24 |
味之素株式会社 |
具有针对抗体的亲和性物质和生物正交性官能团的化合物或其盐
|
|
WO2019246003A1
(en)
|
2018-06-18 |
2019-12-26 |
Anwita Biosciences, Inc. |
Anti-mesothelin constructs and uses thereof
|
|
AU2019316640A1
(en)
|
2018-08-10 |
2021-03-18 |
University Of Massachusetts |
Modified oligonucleotides targeting SNPs
|
|
US11279930B2
(en)
|
2018-08-23 |
2022-03-22 |
University Of Massachusetts |
O-methyl rich fully stabilized oligonucleotides
|
|
EP3856764A4
(en)
|
2018-09-27 |
2022-11-02 |
Xilio Development, Inc. |
MASKED CYTOKINE POLYPEPTIDES
|
|
EP3882261A4
(en)
*
|
2018-10-31 |
2023-02-08 |
Ajinomoto Co., Inc. |
COMPOUND COMPRISING A SUBSTANCE HAVING AN AFFINITY FOR AN ANTIBODY, CLEAVAGE SITE AND CORRESPONDING REACTIVE GROUP OR SALT
|
|
JP2022513198A
(ja)
|
2018-12-10 |
2022-02-07 |
ジェネンテック， インコーポレイテッド |
Ｆｃ含有タンパク質への部位特異的コンジュゲーションのための光架橋性ペプチド
|
|
SG11202105215QA
(en)
*
|
2018-12-20 |
2021-06-29 |
Kleo Pharmaceuticals Inc |
Combination therapy of arms and natural killer cells
|
|
US11492619B2
(en)
|
2019-01-18 |
2022-11-08 |
University Of Massachusetts |
Dynamic pharmacokinetic-modifying anchors
|
|
CA3130174A1
(en)
|
2019-03-15 |
2020-09-24 |
Medimmune Limited |
Azetidobenzodiazepine dimers and conjugates comprising them for use in the treatment of cancer
|
|
BR112022002307A2
(pt)
|
2019-08-09 |
2022-06-28 |
Univ Massachusetts |
Oligonucleotídeos quimicamente modificados que têm como alvo snps
|
|
US12365894B2
(en)
|
2019-09-16 |
2025-07-22 |
University Of Massachusetts |
Branched lipid conjugates of siRNA for specific tissue delivery
|
|
EP3816185A1
(en)
|
2019-11-04 |
2021-05-05 |
Numab Therapeutics AG |
Multispecific antibody directed against pd-l1 and a tumor-associated antigen
|
|
CA3161723A1
(en)
|
2019-12-18 |
2021-06-24 |
Karyn O'neil |
Serum albumin-binding fibronectin type iii domains and uses thereof
|
|
GB201919061D0
(en)
|
2019-12-20 |
2020-02-05 |
Ucb Biopharma Sprl |
Multi-specific antibody
|
|
EP4118438A4
(en)
|
2020-03-09 |
2024-02-28 |
Berkeley Lights, Inc. |
METHODS, SYSTEMS AND KITS FOR TESTING IN A PEN DEVICE
|
|
EP3915580A1
(en)
|
2020-05-29 |
2021-12-01 |
Numab Therapeutics AG |
Multispecific antibody
|
|
JP7748944B2
(ja)
|
2020-06-30 |
2025-10-03 |
株式会社ガイアバイオメディシン |
Ｎｋ細胞と抗体との結合を安定化する方法、及びその利用
|
|
EP3988568A1
(en)
|
2020-10-21 |
2022-04-27 |
Numab Therapeutics AG |
Combination treatment
|
|
WO2022098743A1
(en)
|
2020-11-03 |
2022-05-12 |
Indi Molecular, Inc. |
Compositions, imaging, and therapeutic methods targeting folate receptor 1 (folr1)
|
|
WO2022098745A1
(en)
|
2020-11-03 |
2022-05-12 |
Indi Molecular, Inc. |
Compositions, delivery systems, and methods useful in tumor therapy
|
|
KR20230117588A
(ko)
|
2020-12-07 |
2023-08-08 |
유씨비 바이오파마 에스알엘 |
다중특이적 항체 및 항체 조합
|
|
EP4288451A1
(en)
|
2021-02-02 |
2023-12-13 |
Numab Therapeutics AG |
Multispecific antibodies having specificity for ror1 and cd3
|
|
EP4294834A2
(en)
|
2021-02-19 |
2023-12-27 |
The United States of America, as represented by The Secretary, Department of Health and Human Services |
Single domain antibodies that neutralize sars-cov-2
|
|
JP2024512590A
(ja)
|
2021-03-26 |
2024-03-19 |
アーセルクス インコーポレイテッド |
多機能免疫細胞療法
|
|
MX2023015523A
(es)
|
2021-06-23 |
2024-03-11 |
Univ Massachusetts |
Compuestos de oligonucleotidos anti-flt1 optimizados para el tratamiento de la preeclampsia y otros desordenes angiogenicos.
|
|
EP4183800A1
(en)
|
2021-11-19 |
2023-05-24 |
Medizinische Hochschule Hannover |
Novel sars-cov-2 neutralizing antibodies
|
|
WO2023167564A1
(ko)
|
2022-03-04 |
2023-09-07 |
앱티스 주식회사 |
티올 반응성 에디티브를 이용한 항체-약물 컨쥬게이트의 제조 수율을 높이는 방법
|
|
KR20250019100A
(ko)
|
2022-06-02 |
2025-02-07 |
아지노모토 가부시키가이샤 |
친화성 물질, 화합물, 항체 및 그것들의 염
|
|
MA71385A
(fr)
|
2022-07-08 |
2025-04-30 |
Novo Nordisk A/S |
Composés isvd hautement puissants capables de remplacer fviii(a)
|
|
WO2024038095A1
(en)
|
2022-08-16 |
2024-02-22 |
Iome Bio |
NOVEL ANTI-RGMb ANTIBODIES
|
|
US12233115B2
(en)
|
2022-09-30 |
2025-02-25 |
Extend Biosciences, Inc. |
Long-acting parathyroid hormone
|
|
EP4605077A1
(en)
|
2022-10-18 |
2025-08-27 |
Confo Therapeutics N.V. |
Amino acid sequences directed against the melanocortin 4 receptor and polypeptides comprising the same for the treatment of mc4r-related diseases and disorders
|
|
AU2024277146A1
(en)
*
|
2023-05-22 |
2025-11-27 |
Kaida Biopharmaceuticals, Inc. |
Antagonist fusion polypeptides
|
|
WO2025019077A1
(en)
|
2023-07-18 |
2025-01-23 |
Nanotein Technologies, Inc. |
Reagents, reagent kits, and culture media for activating and expanding immune cells and uses thereof
|
|
US12377158B1
(en)
*
|
2024-07-05 |
2025-08-05 |
Michael Farber |
Enhanced peptide constructs for albumin binding
|